Clinical Research Solutions PC

Jackson, Tennessee 38305

0 studies enrolling now · 2 studies all time

What they study most

Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome

Studies at this site

• Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) — Completed
• Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome — Completed